Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy
GALVANI PS-1
Personalized Multichannel Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epilepsy: Evaluation of Therapeutic and Neurophysiological Effects
2 other identifiers
interventional
17
1 country
1
Brief Summary
This project aims to conduct a pilot study based on the targeting of the epileptogenic zone previously localized very precisely by stereoelectroencephalography (SEEG). SEEG is used as part of the pre-surgical assessment. It consists, thanks to the intracerebral implantation of electrodes in the brain of patients, to perform an intracerebral electrophysiological recording and thus to precisely explore the epileptogenic regions. In order to study the neuromodulatory and therapeutic effects of tDCS on epileptic brains, non-invasive techniques for measuring electrophysiological brain activity such as magnetoencephalography (MEG) and high-resolution electroencephalography (HR EEG) will be used. Finally, since epilepsy is considered to be a disorder of brain functional networks associated with disturbed brain connectivity, the effects of tDCS on cortical excitability by studying the variations in functional connectivity induced by stimulation will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedStudy Start
First participant enrolled
March 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2024
CompletedMay 8, 2026
February 1, 2024
1.9 years
February 26, 2021
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Seizure frequency
Percentage of change of seizures frequency
Comparison between baseline and month 2
Seizure frequency
Percentage of change of seizures frequency
Comparison between baseline and month 4
Seizure frequency
Percentage of change of seizures frequency
Comparison between baseline and month 6
Seizure frequency
Percentage of change of seizures frequency
Comparison between baseline and month 8
Secondary Outcomes (4)
Depression
Comparison between baseline and month 8
Anxiety disorders
Comparison between baseline and month 8
Seizures evaluation
Comparison between baseline and month 8
Brain functional connectivity
Comparison between day 1 and day 5 of each session
Study Arms (1)
tDCS (transcranial direct current stimulation)
EXPERIMENTALPatient will be treated for 3 cycles. A cycle is composed of 5 bi-sessions (one per day) of 20 minutes each.
Interventions
Patients will be treated using Starstim 8 device, a device allowing to perform transcranial direct current stimulation. The position of electrodes will be personalized based on the localization of the epileptogenic zone.
Eligibility Criteria
You may qualify if:
- \- Age: Older than 12 years old
- Patients with drug-resistant focal epilepsy with no surgical indication or with a previous surgical failure or refusing surgery.
- A clinical or research MRI scan that is suitable for navigated brain stimulation (NBS) and definition of target area.
- Number of seizures \>3/month during the baseline (before the first session of tDCS treatment), for at least 3 months
- Have stable medications for the whole study duration and few weeks before
- Total IQ\>65
- Be able to understand, speak and write in French
- Patient, parents or legally representative who have given written informed consent to allow the study data collection procedures,
- Be a beneficiary of affiliated to a health insurance plan
You may not qualify if:
- \- Generalized epilepsy
- Presenting contraindication to MRI, a serious intercurrent pathology, a progressive brain tumor
- Skin conditions (e.g., eczema, lesion)
- Any cranial metal implants (excluding \<1 mm thick epicranial titanium skull plates and dental fillings) or medical devices (i.e. cardiac pacemaker, deep brain stimulator, medication infusion pump, cochlear implant).
- Previous surgeries opening the skull leaving skull defects capable of allowing the insertion of a cylinder with a radius greater or equal to 5 mm.
- Metal inside the head (outside the mouth) such as shrapnel, surgical clips
- Any condition that makes the study subject, in the opinion of the investigator, unsuitable for the study.
- Person protected by articles L1121-5, L1121-6 and L1121-8 of Public Health Code (pregnant or breastfeeding woman, deprived of liberty by judicial decision, situations of social fragility, adults unable or unable to express their consent).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service d'Epileptologie et de Rythmologie Cérébrale
Marseille, 13005, France
Related Publications (1)
Bartolomei F, Daoud M, Delourme M, Tardoski S, Makhalova J, Bourguiba E, Medina Villalon S, Lagarde S, Wendling F, Ruffini G, Salvador R, Pizzo F, Giusiano B. Personalized multichannel transcranial direct current electrical stimulation (tDCS) in drug-resistant epilepsy: A SEEG based open-labeled study. Epilepsia Open. 2025 Aug;10(4):1034-1042. doi: 10.1002/epi4.70055. Epub 2025 May 10.
PMID: 40347434RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean-Olivier Arnaud
AP-HM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2021
First Posted
March 4, 2021
Study Start
March 15, 2021
Primary Completion
February 20, 2023
Study Completion
February 21, 2024
Last Updated
May 8, 2026
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share